Article Details

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Consensus Rating of "Buy" by Analysts

Retrieved on: 2021-05-28 09:47:33

Tags for this article:

Click the tags to see associated articles and topics

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Consensus Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 790,880 shares of the company's stock valued at $26,273,000 after buying an additional 73,968 shares during the period.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up